1 Strong Dividend Stock You Can Buy Right Now
Bank certificates of deposit and savings accounts pay almost nothing in interest right now. Fortunately, investors on the hunt for income don't need to gamble on the riskiest stocks out there.
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.
Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences
European approval of Bristol-Myers Squibb's Daklinza could derail sales of Johnson & Johnson's Olysio, but is unlikely to unseat Gilead's Sovaldi.